Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Non-Small-Cell Lung | 18 | 2023 | 5303 | 2.150 |
Why?
|
Lung Neoplasms | 24 | 2024 | 13333 | 1.780 |
Why?
|
Medical Oncology | 8 | 2024 | 2321 | 1.660 |
Why?
|
Neoplasms | 16 | 2024 | 22158 | 1.250 |
Why?
|
Artificial Intelligence | 7 | 2024 | 2578 | 0.950 |
Why?
|
Natural Language Processing | 5 | 2024 | 1162 | 0.830 |
Why?
|
Electronic Health Records | 7 | 2024 | 4812 | 0.760 |
Why?
|
Colorectal Neoplasms | 8 | 2024 | 6901 | 0.740 |
Why?
|
Preferred Provider Organizations | 1 | 2019 | 38 | 0.680 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2022 | 11735 | 0.580 |
Why?
|
Genetic Testing | 4 | 2020 | 3538 | 0.550 |
Why?
|
Genomics | 8 | 2024 | 5817 | 0.530 |
Why?
|
Health Plan Implementation | 1 | 2019 | 337 | 0.520 |
Why?
|
Databases, Genetic | 1 | 2021 | 1738 | 0.480 |
Why?
|
Small Cell Lung Carcinoma | 2 | 2019 | 422 | 0.460 |
Why?
|
Cancer Care Facilities | 1 | 2017 | 422 | 0.450 |
Why?
|
Proportional Hazards Models | 4 | 2024 | 12450 | 0.440 |
Why?
|
Patient Participation | 3 | 2020 | 1443 | 0.410 |
Why?
|
Genes, BRCA2 | 1 | 2015 | 601 | 0.410 |
Why?
|
Choice Behavior | 2 | 2015 | 824 | 0.400 |
Why?
|
Patient Preference | 2 | 2020 | 926 | 0.390 |
Why?
|
Genes, BRCA1 | 1 | 2015 | 764 | 0.390 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2024 | 2210 | 0.380 |
Why?
|
BRCA2 Protein | 1 | 2016 | 804 | 0.370 |
Why?
|
Health Services Accessibility | 2 | 2019 | 5439 | 0.360 |
Why?
|
Insurance, Health | 3 | 2019 | 2495 | 0.340 |
Why?
|
Specialization | 1 | 2014 | 779 | 0.340 |
Why?
|
SEER Program | 3 | 2020 | 1449 | 0.340 |
Why?
|
BRCA1 Protein | 1 | 2016 | 1155 | 0.330 |
Why?
|
Medical Records | 1 | 2015 | 1408 | 0.330 |
Why?
|
Immunotherapy | 3 | 2021 | 4649 | 0.320 |
Why?
|
Colonic Neoplasms | 2 | 2024 | 2534 | 0.310 |
Why?
|
Survivors | 2 | 2016 | 2370 | 0.310 |
Why?
|
Neoplasm Staging | 7 | 2022 | 11098 | 0.300 |
Why?
|
Poverty | 1 | 2019 | 2697 | 0.280 |
Why?
|
Humans | 53 | 2024 | 761326 | 0.280 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2017 | 1186 | 0.280 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2248 | 0.270 |
Why?
|
Antineoplastic Agents | 3 | 2024 | 13635 | 0.270 |
Why?
|
Aged | 24 | 2024 | 169179 | 0.270 |
Why?
|
Withholding Treatment | 2 | 2021 | 617 | 0.260 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3200 | 0.260 |
Why?
|
Survival Analysis | 4 | 2024 | 10075 | 0.250 |
Why?
|
Cisplatin | 2 | 2022 | 1647 | 0.250 |
Why?
|
Breast Neoplasms | 3 | 2018 | 21009 | 0.250 |
Why?
|
Medicare | 6 | 2023 | 6758 | 0.250 |
Why?
|
Quality of Health Care | 2 | 2023 | 4330 | 0.240 |
Why?
|
Patient Care Team | 1 | 2015 | 2523 | 0.220 |
Why?
|
Patient Selection | 2 | 2019 | 4244 | 0.220 |
Why?
|
Communication | 2 | 2015 | 3870 | 0.220 |
Why?
|
Electric Power Supplies | 1 | 2023 | 97 | 0.210 |
Why?
|
Female | 28 | 2024 | 392485 | 0.210 |
Why?
|
Poisson Distribution | 1 | 2024 | 504 | 0.210 |
Why?
|
Hospitalization | 3 | 2021 | 10715 | 0.210 |
Why?
|
Aged, 80 and over | 10 | 2021 | 58946 | 0.210 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2023 | 101 | 0.200 |
Why?
|
United States | 11 | 2023 | 72317 | 0.200 |
Why?
|
Antibodies, Monoclonal | 1 | 2019 | 9180 | 0.200 |
Why?
|
Selection Bias | 2 | 2022 | 359 | 0.200 |
Why?
|
Decision Making | 2 | 2020 | 3929 | 0.200 |
Why?
|
Physician-Patient Relations | 1 | 2015 | 3249 | 0.190 |
Why?
|
Retrospective Studies | 12 | 2024 | 80575 | 0.180 |
Why?
|
Biometry | 1 | 2024 | 562 | 0.180 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2024 | 3638 | 0.180 |
Why?
|
Male | 23 | 2024 | 360621 | 0.180 |
Why?
|
Middle Aged | 17 | 2024 | 220774 | 0.170 |
Why?
|
Proxy | 1 | 2020 | 151 | 0.160 |
Why?
|
Molecular Sequence Annotation | 1 | 2021 | 523 | 0.160 |
Why?
|
Colitis, Microscopic | 1 | 2020 | 72 | 0.160 |
Why?
|
Mutation | 5 | 2024 | 30044 | 0.160 |
Why?
|
International Classification of Diseases | 1 | 2024 | 909 | 0.160 |
Why?
|
Carboplatin | 1 | 2021 | 794 | 0.150 |
Why?
|
Health Care Surveys | 2 | 2015 | 2426 | 0.150 |
Why?
|
Taxoids | 1 | 2021 | 666 | 0.150 |
Why?
|
Peritoneal Neoplasms | 1 | 2024 | 711 | 0.140 |
Why?
|
Causality | 1 | 2023 | 1243 | 0.140 |
Why?
|
Prognosis | 5 | 2022 | 29588 | 0.130 |
Why?
|
Pneumonectomy | 1 | 2023 | 1110 | 0.130 |
Why?
|
Radiation Oncology | 1 | 2022 | 563 | 0.130 |
Why?
|
Fatigue | 2 | 2022 | 1551 | 0.130 |
Why?
|
Kaplan-Meier Estimate | 2 | 2016 | 6473 | 0.120 |
Why?
|
Rectal Neoplasms | 1 | 2024 | 1157 | 0.120 |
Why?
|
Infusions, Intravenous | 1 | 2020 | 2217 | 0.120 |
Why?
|
Survival Rate | 3 | 2019 | 12710 | 0.120 |
Why?
|
Medicaid | 2 | 2019 | 2817 | 0.120 |
Why?
|
Regression Analysis | 1 | 2024 | 6341 | 0.120 |
Why?
|
Deoxycytidine | 1 | 2018 | 875 | 0.110 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12059 | 0.110 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2022 | 3512 | 0.110 |
Why?
|
Cohort Studies | 4 | 2022 | 41440 | 0.110 |
Why?
|
Accreditation | 1 | 2017 | 473 | 0.110 |
Why?
|
Information Seeking Behavior | 1 | 2014 | 116 | 0.110 |
Why?
|
Pilot Projects | 2 | 2024 | 8632 | 0.110 |
Why?
|
Drug Approval | 1 | 2020 | 814 | 0.100 |
Why?
|
Cyclophosphamide | 1 | 2018 | 2218 | 0.100 |
Why?
|
Logistic Models | 3 | 2020 | 13251 | 0.100 |
Why?
|
Doxorubicin | 1 | 2018 | 2215 | 0.100 |
Why?
|
Colitis | 1 | 2020 | 1231 | 0.100 |
Why?
|
United States Food and Drug Administration | 1 | 2020 | 1665 | 0.090 |
Why?
|
Computer Simulation | 1 | 2024 | 6236 | 0.090 |
Why?
|
Comorbidity | 2 | 2015 | 10498 | 0.090 |
Why?
|
Adrenal Cortex Hormones | 1 | 2019 | 1875 | 0.090 |
Why?
|
Genotype | 2 | 2021 | 12982 | 0.090 |
Why?
|
Comprehension | 1 | 2015 | 621 | 0.080 |
Why?
|
Models, Statistical | 1 | 2024 | 5078 | 0.080 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 931 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2015 | 7999 | 0.080 |
Why?
|
Perception | 1 | 2015 | 1197 | 0.080 |
Why?
|
Linear Models | 1 | 2018 | 5871 | 0.080 |
Why?
|
Age Factors | 2 | 2015 | 18401 | 0.080 |
Why?
|
Insurance Coverage | 1 | 2019 | 1938 | 0.080 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1504 | 0.070 |
Why?
|
Radiology | 1 | 2021 | 2113 | 0.070 |
Why?
|
Disease Progression | 1 | 2023 | 13500 | 0.070 |
Why?
|
Time Factors | 2 | 2020 | 39974 | 0.070 |
Why?
|
Pancreatic Neoplasms | 1 | 2024 | 5363 | 0.070 |
Why?
|
Income | 1 | 2014 | 1876 | 0.060 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2020 | 2421 | 0.060 |
Why?
|
Lung | 2 | 2024 | 9994 | 0.060 |
Why?
|
Minority Groups | 2 | 2023 | 1203 | 0.060 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7824 | 0.060 |
Why?
|
Adult | 7 | 2020 | 221122 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2019 | 4022 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2022 | 12666 | 0.050 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3357 | 0.050 |
Why?
|
Odds Ratio | 1 | 2015 | 9639 | 0.050 |
Why?
|
Interleukin-7 | 1 | 2022 | 142 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2015 | 3889 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39108 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2015 | 4014 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2023 | 11116 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 14665 | 0.040 |
Why?
|
Neoplasm Metastasis | 2 | 2022 | 4908 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 634 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2020 | 9030 | 0.040 |
Why?
|
Advance Directives | 1 | 2020 | 248 | 0.040 |
Why?
|
Research Report | 1 | 2021 | 367 | 0.040 |
Why?
|
Ambulatory Care Facilities | 1 | 2024 | 934 | 0.040 |
Why?
|
Quality of Life | 1 | 2019 | 13355 | 0.040 |
Why?
|
Pancreas | 1 | 2024 | 1689 | 0.030 |
Why?
|
Molecular Targeted Therapy | 2 | 2019 | 2811 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 1742 | 0.030 |
Why?
|
Population Groups | 1 | 2016 | 208 | 0.030 |
Why?
|
Prospective Studies | 2 | 2021 | 54405 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2423 | 0.030 |
Why?
|
Medical Informatics | 1 | 2020 | 733 | 0.030 |
Why?
|
Terminology as Topic | 1 | 2020 | 1535 | 0.030 |
Why?
|
Young Adult | 2 | 2016 | 59196 | 0.030 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 26108 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2022 | 2911 | 0.020 |
Why?
|
Data Collection | 1 | 2021 | 3324 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2021 | 1175 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2019 | 4850 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2023 | 4509 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2015 | 64645 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2021 | 3356 | 0.020 |
Why?
|
Registries | 1 | 2024 | 8223 | 0.020 |
Why?
|
Cognition | 1 | 2022 | 6987 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10203 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15835 | 0.010 |
Why?
|
Animals | 1 | 2024 | 168388 | 0.010 |
Why?
|
Adolescent | 1 | 2016 | 88305 | 0.000 |
Why?
|
Concepts
(162)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(88)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_